MIR205HG and neoplasm: In both TCGA and GSE21034 cohorts, LEADR/MIR205HG expression alone was able to discriminate tumor vs. normal samples (Fig. 1d), suggesting that LEADR/MIR205HG loss may be an inescapable early event in prostate carcinogenesis.